Prevention and Treatment of Surgical Site Infections
Elizabeth A. Rice, MD,* and Thomas R. Talbot, MD, MPH†
Surgical site infections (SSIs) are a major cause of postoperative illness, longer hospitalization, and increased healthcare costs, making the prevention and treatment of SSIs an important aspect of patient care for hospitalists. The following module outlines the different patient and procedural risk factors that influence SSIs, examines the basic principles of antimicrobial prophylaxis for SSI, reviews nonantibiotic interventions to lessen the risk of SSI, and outlines evaluation for and treatment of an SSI. In addition, a discussion of the controversy surrounding preoperative decolonization of Staphylococcus aureus is provided.
After completing the module, the participant should be able to:
- Identify patient- and procedure-associated risk factors for the development of surgical site infections (SSIs).
- Discuss the basic principles of antimicrobial prophylaxis for SSI, including aspects of drug selection, timing of administration, and the need for intraoperative redosing during prolonged surgical cases.
- Describe nonantibiotic interventions designed to reduce a patient’s risk of developing SSIs, including prevention of hypothermia, reduction of hyperglycemia, and appropriate hair removal practices.
- Evaluate the controversy surrounding preoperative decolonization of Staphylococcus aureus.
- Develop an approach to the assessment and treatment of a patient with a possible SSI.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: December 15, 2008. Expiration date: December 15, 2012.
*Assistant Professor of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
†Assistant Professor of Medicine, Chief Hospital Epidemiologist, Vanderbilt University Medical Center, Nashville, Tennessee.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.
